12 Slide Neurodegenerative Pitch Deck Template

Neurodegenerative diseases don’t just affect lives—they redefine them. If you’ve ever felt the helplessness of watching someone you love lose pieces of themselves to diseases like Alzheimer’s, Parkinson’s, or ALS, you’re not alone. And that gut-wrenching feeling of inevitability? It doesn’t have to be the norm.

I’m Viktor, a pitch deck expert and creative business strategist. Over the past 13 years, I’ve helped businesses secure millions of $ in funding thanks to my approach and I’m sharing it here in this pitch deck guide.

This guide is here to help you weave a pitch that not only wins minds but touches hearts. So, grab a coffee (or tea, no judgment), and let’s tackle the basics of creating a pitch deck that moves the needle on funding neurodegenerative innovation.

Get My 12 Slide Framework That Got $500mil in Funding For Clients.

What do you think of having 12 dead simple formulas, that will help you craft 12 slides, in about 1 hour? That’s what you’ll get, when you download my 12 slide framework. Save hours crafting your pitch deck copy with my tested approach that includes:

Elevator pitch one sentence formula
Problem/ solution slide one sentence formula
Competitor slide one sentence formula
9 other formulas, tips, tricks and advice

The formulas worked for 40+ industries and 500+ companies. Including the one you’re looking at now.

Get it On Gumroad

Get It On Patreon

Clicking the link won’t charge you anything.

“The amount of know-how Viktor has about the industry is astounding. No wonder he can build a pitch deck for just about any product or service; completely hands-off.”

★★★★★

Get an investor ready pitch deck that gets you funded and saves over 30 hours of your time.

Join 100s of successful entrepreneurs who’ve transformed their pitch decks by using my hands-off approach, which includes: market research, copy, design, financials, narrative and strategy.

1 week turnaround time and less. Special pricing for early stage companies.

Start Winning Investors. Book The Free Exploratory Call.

The least you will get on this call is 10 actionable tips & strategies to own that next pitch, worth $599, for free.

top-rated-pitch-deck-expert-on-upwork-viktor-ilijev

12 Slide Neurodegenerative Disease Pitch Deck Template | Google Slides

The above is is just a simplified pitch deck version developed as part of our entrepreneurship program for graduate studies.

Founders that are serious about getting the funding they need, opt in for a deck has industry specific content, superb narrative and award winning design like these ones below:

I can help you build that deck with my hands-off process in 7 days or less.

Book a free 30 minute call below if you’re serious about getting an investor ready deck, and we’ll discuss your needs in detail. I’ll help you design the deck, write the content, develop the narrative and flesh out the strategy with financials.

Book the free call

We help 15,000+ founders every month create better pitch decks.

Alternatively, get the custom template for just $69,99.

★★★★★

As soon as the payment is processed I’ll send over a quick questionnaire and deliver the deck in 24 hours and less.

Slide 1: Title Slide

Title: ExoNeuro: Revolutionizing Treatment for Neurodegenerative Diseases
Subtitle: Harnessing the Power of Exosomes for Brain Health
Presented by: Viktor, Founder & CEO
Contact Information: [email@example.com] | [Phone Number]
Company Logo

Slide 2: Problem Statement

Headline: The Rising Tide of Neurodegenerative Diseases

Key Points:

Prevalence and Impact:
- Over 50 million people worldwide are affected by neurodegenerative diseases, with numbers expected to rise dramatically due to an aging population.
- Alzheimer’s disease alone is projected to affect 82 million people by 2030 and 152 million by 2050.
Current Treatment Limitations:
- Existing therapies primarily offer symptomatic relief rather than addressing the underlying disease mechanisms.
- High treatment costs and prolonged care needs place a significant burden on healthcare systems and families.
Unmet Medical Needs:
- Lack of disease-modifying treatments highlights a critical gap in current medical research and pharmaceutical development.
- The urgent need for innovative approaches that can halt or reverse disease progression.

Slide 3: Solution

Headline: Exosome-Based Therapeutics: A Paradigm Shift

Key Points:

Introduction to Exosomes:
- Exosomes are small extracellular vesicles that facilitate intercellular communication, transporting proteins, lipids, and RNA molecules.
- Naturally occurring, they have a unique ability to cross the blood-brain barrier, making them ideal for neurological applications.
Our Innovative Approach:
- Developing exosome-based compounds specifically designed to target and treat neurodegenerative diseases.
- Leveraging the regenerative properties of exosomes to promote neuronal survival, reduce inflammation, and enhance cellular repair mechanisms.
Therapeutic Potential:
- Exosome-based therapies offer a novel approach with the potential to modify the disease course, providing long-term benefits and improved quality of life for patients.

Slide 4: Technology Overview

Headline: Cutting-Edge Technology for Precision Medicine

Key Points:

Development Process:
- Isolation and purification of exosomes from stem cells using proprietary technology.
- Engineering exosomes to carry therapeutic cargo tailored for specific neurodegenerative diseases.
- Ensuring high purity and consistency through advanced manufacturing processes.
Advantages Over Traditional Therapies:
- Targeted delivery system minimizes off-target effects and enhances therapeutic efficacy.
- Natural origin reduces the risk of immune rejection and adverse reactions.
- Ability to cross the blood-brain barrier enables direct treatment of brain tissues.
Intellectual Property:
- Patent-pending technologies and proprietary methods safeguard our innovations.
- Strong IP portfolio positions us as a leader in the exosome therapeutics market.

Slide 5: Market Opportunity

Headline: A Growing Market with Unmet Needs

Key Points:

Market Size and Growth:
- The global market for neurodegenerative disease treatments is expected to reach $11.1 billion by 2027, growing at a CAGR of 7.2%.
- Increasing demand for effective therapies driven by rising disease prevalence and aging demographics.
Competitive Landscape:
- Current market dominated by symptomatic treatments with limited competition in disease-modifying therapies.
- Opportunity to differentiate through innovative exosome-based solutions.
Key Market Drivers:
- Advances in biotechnology and growing investment in neurodegenerative research.
- Favorable regulatory environment encouraging the development of novel therapies.
- Increasing awareness and diagnosis rates of neurodegenerative diseases.

Slide 6: Product Development Timeline

Headline: From Concept to Market

Key Points:

Current Stage:
- Completed preclinical studies demonstrating safety and efficacy in animal models.
- Initiated early-stage clinical trials to assess safety, dosage, and preliminary efficacy in humans.
Milestones Achieved:
- Successful isolation and engineering of therapeutic exosomes.
- Positive preclinical results showing neuroprotective effects and reduced disease progression.
- Secured funding and partnerships for initial clinical development.
Future Roadmap:
- 2024-2025: Conduct Phase I clinical trials to establish safety and optimal dosing.
- 2025-2026: Initiate Phase II trials to evaluate efficacy in a larger patient population.
- 2026-2028: Phase III trials and regulatory submissions for market approval.
- 2029: Launch exosome-based therapeutics in key markets, scaling production and distribution.

Hold on. You might want to check my list on the best presentation and communication books...

These are crucial books that will help you improve the design and structure of your decks and presentations, besides improving your delivery and skyrocketing your confidence when facing investors. Check them out below.

10 Best Presentation Books

26 Best Communication Books

Slide 7: Clinical Strategy

Headline: Paving the Path to Approval

Key Points:

Clinical Trial Design:
- Phase I: Safety and dosage determination in a small group of patients. Focus on assessing tolerability and identifying potential side effects.
- Phase II: Efficacy and side effects evaluation in a larger group. Determining the optimal dose that provides the best balance of efficacy and safety.
- Phase III: Large-scale testing to confirm efficacy, monitor side effects, and compare with current standard treatments.
Regulatory Strategy:
- Engaging with regulatory bodies like the FDA and EMA early in the development process.
- Submitting Investigational New Drug (IND) applications with comprehensive preclinical data.
- Adopting a fast-track designation or breakthrough therapy designation if applicable, to expedite the approval process.
Safety and Efficacy Endpoints:
- Primary endpoints: Improvement in cognitive function, reduction in disease biomarkers.
- Secondary endpoints: Quality of life improvements, reduction in caregiver burden.

Slide 8: Scientific Evidence

Headline: Robust Preclinical and Clinical Data

Key Points:

Preclinical Studies:
- Animal models demonstrating significant neuroprotective effects and slowing of disease progression.
- Evidence of reduced inflammation and enhanced neuronal survival.
- Safety profile indicating minimal adverse reactions and good tolerability.
Clinical Trials:
- Early-phase human trials showing promising safety results and initial signs of efficacy.
- Positive feedback from patients and healthcare providers involved in the trials.
Supporting Literature:
- Citing recent studies and publications highlighting the potential of exosome-based therapies.
- Expert endorsements from leading neurologists and researchers in the field of neurodegenerative diseases.

Slide 9: Business Model

Headline: Sustainable and Scalable Business Model

Key Points:

Revenue Streams:
- Licensing agreements with pharmaceutical companies for co-development and commercialization.
- Direct sales of exosome-based therapeutics to healthcare providers and institutions.
- Potential for personalized medicine approaches, tailoring treatments to individual patient profiles.
Pricing Strategy:
- Competitive pricing models compared to existing therapies, considering the innovative nature and potential for disease modification.
- Reimbursement strategies to ensure accessibility through insurance coverage and government healthcare programs.
Go-to-Market Strategy:
- Strategic partnerships with key stakeholders in the healthcare industry.
- Leveraging existing networks and relationships with hospitals, clinics, and research institutions.
- Focused marketing campaigns to raise awareness among healthcare professionals and patient advocacy groups.

Slide 10: Financial Projections

Headline: Financial Outlook and Investment Needs

Key Points:

Financial Projections:
- Revenue projections based on market penetration rates and pricing models.
- Detailed expense forecasts, including R&D, manufacturing, marketing, and regulatory compliance.
- Profit margins and break-even analysis.
Funding Requirements:
- Total funding needed to reach key milestones and achieve market launch.
- Breakdown of funding allocation: clinical trials, regulatory submissions, production scale-up, and marketing efforts.
Expected ROI:
- Projected return on investment for early-stage investors.
- Exit strategies, including potential acquisition by a larger pharmaceutical company or public offering.

Slide 11: Team

Headline: Experienced Team with a Vision

Key Points:

Leadership Team:
- Viktor, Founder & CEO: Over 13 years of experience in biotech and neurodegenerative disease research. Proven track record in leading successful startups.
- Chief Scientific Officer: Renowned neuroscientist with extensive experience in exosome research and development.
- Chief Medical Officer: Expert in clinical trials and regulatory affairs, with a history of successful drug approvals.
Advisory Board:
- Comprising leading experts in neurology, biotechnology, and pharmaceutical development.
- Strategic advisors from top academic institutions and industry leaders.
Key Partners:
- Collaborations with research institutions, hospitals, and biotech companies to advance R&D efforts.

Slide 12: Call to Action

Headline: Join Us in Transforming Brain Health

Key Points:

Summary of the Opportunity:
- Highlighting the potential impact of exosome-based therapies on neurodegenerative diseases.
- Emphasizing the innovative nature and unique advantages of our approach.
Specific Ask:
- Seeking investment to fund upcoming clinical trials and regulatory submissions.
- Looking for strategic partners to collaborate on R&D and commercialization efforts.
- Inviting potential clinical trial participants and advocacy groups to support our mission.
Next Steps:
- Contact information for follow-up discussions.
- Schedule of upcoming investor meetings and presentations.
- Invitation to visit our facilities and meet the team.

Pick a specific pitch deck design from the award winning Envato.

1000’s of ready made Powerpoint, Google Slides, and Keynote presentations that are easy to edit, format and tailor to your idea.

Grab The Deal And Build Your Deck

Last Words

There you have it—the roadmap to turning your passion for tackling neurodegenerative diseases into a compelling pitch deck that gets people to lean in, not tune out. This isn’t about throwing slides together; it’s about creating a story that makes people feel the urgency, see the opportunity, and believe in your vision.

Remember, the pitch isn’t the end goal—it’s the bridge. A bridge between your idea and the resources you need to make it a reality. If you’ve followed this template, you’re well on your way to building that bridge.

And hey, if the thought of piecing all this together still feels daunting, I’m here to help. Pitching is my playground, and I’d love to team up to craft something memorable.

Let’s make sure your innovation isn’t just seen—it’s unstoppable.

You got this!

But if you don’t got it:

Join hundreds of successful entrepreneurs who’ve transformed their pitch decks with my help.

Let me develop an investor ready deck by using my hands-off approach, which includes: market research, copy, design, financials, narrative and strategy.

One week turnaround time.

Book The Free Strategy Call. Limited Slots Available.

The least you will get is 10 actionable tips & strategies to own that next presentation, worth $599, for free.